Zobrazeno 1 - 10
of 27
pro vyhledávání: '"A. N. Kaburova"'
Autor:
A. N. Kaburova, O. M. Drapkina, S. M. Yudin, A. A. Yafarova, S. N. Koretsky, M. S. Pokrovskaya, V. V. Makarov, S. A. Kraevoy, B. B. Shoibonov, I. A. Efimova, Z. Z. Serebryanskaya
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 21, Iss 9 (2022)
Aim. To study the relationship between the abundance of the genera in the gut microbiota (GM) and levels of serum biomarkers of chronic systemic inflammation and endotoxemia in patients with HFpEF.Material and methods. The composition of GM among 42
Externí odkaz:
https://doaj.org/article/0568c068bd9448acb0aac27e45de0338
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 48, Iss 5, Pp 325-332 (2020)
Background: The assessment of diffuse myocardial fibrosis is necessary to plan the management of patients with various cardiovascular disorders, including hypertensive heart disease. The development of imaging techniques has enabled a non-invasive de
Externí odkaz:
https://doaj.org/article/c98815daa3c94d2281496663b88b8480
Autor:
O. M. Drapkina, A. N. Kaburova
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 16, Iss 2, Pp 277-285 (2020)
Chronic noncommunicable diseases represent one of the key medical problems of the XXI century. In this group cardiovascular diseases (CVD) are known to be the leading cause of death which pathogenesis still has the potential to be more profoundly rev
Externí odkaz:
https://doaj.org/article/8d57a57dab9d47038934524e19709e5e
Autor:
A. N. Kaburova, O. M. Drapkina, S. M. Yudin, S. N. Koretsky, V. V. Makarov, M. S. Pokrovskaya, S. A. Kraevoy, B. B. Shoybonov, I. A. Efimova
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 20, Iss 4 (2021)
Aim. To study the relationship of gut microbiota (GM) with serum myocardial fibrosis markers in patients with heart failure with preserved ejection fraction (HFpEF).Material and methods. The composition of the gut microbiota among 42 patients with HF
Externí odkaz:
https://doaj.org/article/5461fbb0a80b45b19e4f0569c9e56d50
Autor:
O. M. Drapkina, R. N. Shepel, E. S. Ivanova, E. S. Bulgakova, A. N. Kaburova, L. M. Zhamalov, Yu. D. Shalyagin, A. V. Kutcher, S. A. Vernadskiy
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 15, Iss 2, Pp 209-214 (2019)
Aim. To perform an arterial hypertension (HT) screening for assessing the awareness of Moscow Region citizens about high blood pressure (BP) and draw their attention to this important risk factor.Material and methods. The screening was performed as a
Externí odkaz:
https://doaj.org/article/b24e404fea76484d90bbfa150d083554
Autor:
O. M. Drapkina, A. I. Martynov, A. P. Baida, V. E. Balan, I. I. Baranov, E. E. Vlasova, P. A. Vorobiev, S. A. Volkova, I. Yu. Gaiduk, Zh. A. Gornostaeva, N. Yu. Grigorieva, Yu. E. Dobrokhotova, L. I. Dvoretskiy, G. B. Dikke, V. F. Dolgushina, O. V. Dunicheva, E. V. Eliseeva, E. V. Ivanova, N. A. Koryagina, T. A. Kunyaeva, V. I. Kupaev, T. A. Mitina, M. E. Mozheiko, T. A. Oboskalova, S. V. Orlova, T. Yu. Pestrikova, N. P. Sanina, E. I. Sas, G. Sh. Safuanova, T. M. Sokolova, N. I. Stuklov, N. L. Tov, L. V. Tribuntseva, Z. A. Umarova, L. S. Fatkullina, A. V. Fendrikova, O. V. Khlynova, G. V. Shavkuta, Yu. A. Sharapova, E. V. Shikh, R. N. Shepel, A. N. Kaburova
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 19, Iss 5 (2020)
It is known that iron deficiency is a negative factor for the onset of pregnancy. It aggravates its course, increasing the risk of preeclampsia, placental insufficiency, uterine inertia, premature birth, bleeding and hypogalactia. This condition incr
Externí odkaz:
https://doaj.org/article/59a3257c7daf477d81064af368ac9d52
Autor:
O. M. Drapkina, A. N. Kaburova
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 12, Iss 1, Pp 66-71 (2016)
The last decade is marked by the significant reinterpretation of the gut microbiota contribution to chronic disease progression. The researchers’ careful attention is focused on improving the understanding of the metabolic pathways of two dietary c
Externí odkaz:
https://doaj.org/article/ecc42a97c8fa41f8891760ac58abc046
Autor:
Oxana M. Drapkina, German A. Ashniev, Olga A. Zlobovskaya, Adel A. Yafarova, Elena V. Dementeva, Anastasia N. Kaburova, Ivan O. Meshkov, Anna F. Sheptulina, Anton R. Kiselev, Anna V. Kontsevaya, Linar M. Zhamalov, Sergey N. Koretskiy, Mariya S. Pokrovskaya, Alexandra I. Akinshina, Anjelica V. Zagaynova, Mariia V. Lukashina, Andrey V. Kirillov, Ivan A. Abramov, Larisa R. Tolkacheva, Irina O. Bikaeva, Evgeniya V. Glazunova, German A. Shipulin, Maria M. Bobrova, Valentin V. Makarov, Anton A. Keskinov, Vladimir S. Yudin, Sergey M. Yudin
Publikováno v:
Biomedicines; Volume 10; Issue 11; Pages: 2762
To continue progress in the treatment of cardiovascular disease, there is a need to improve the overall understanding of the processes that contribute to the pathogenesis of cardiovascular disease (CVD). Exploring the role of gut microbiota in variou
Publikováno v:
Biomedicines. 10(8)
Cardiovascular diseases (CVDs) remain the major public health concern worldwide. Over the last two decades, a considerable amount of literature has been published on gut microbiota (GMB) composition and its metabolites, involved in the pathophysiolog
Autor:
A. N. Kaburova, O. M. Drapkina
Publikováno v:
Racionalʹnaâ Farmakoterapiâ v Kardiologii, Vol 16, Iss 2, Pp 277-285 (2020)
Chronic noncommunicable diseases represent one of the key medical problems of the XXI century. In this group cardiovascular diseases (CVD) are known to be the leading cause of death which pathogenesis still has the potential to be more profoundly rev